+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
microRNA Market by Product Type, Application, End User - Global Forecast to 2030- Product Image
microRNA Market by Product Type, Application, End User - Global Forecast to 2030- Product Image
Sale

microRNA Market by Product Type, Application, End User - Global Forecast to 2030

  • PDF Icon

    Report

  • 181 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5666324
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The microRNA Market grew from USD 2.72 billion in 2024 to USD 3.54 billion in 2025. It is expected to continue growing at a CAGR of 28.98%, reaching USD 12.55 billion by 2030.

Unlocking microRNA's Role in Health and Disease

microRNAs have emerged as pivotal regulators of gene expression, orchestrating cellular processes that underpin health and disease. These short, non-coding RNA molecules fine-tune protein synthesis by targeting messenger RNA transcripts, influencing pathways that range from development to immune response. Over the past decade, microRNA research has transitioned from fundamental discovery to translational impact, with diagnostic tests and therapeutic candidates entering clinical pipelines.

As scientific interest intensifies, the need for a consolidated overview has become paramount. This executive summary distills the latest developments in technologies, regulatory shifts, and market dynamics shaping the microRNA landscape. It provides stakeholders-ranging from laboratory directors to strategic investors-with a clear understanding of current opportunities and challenges. By framing the narrative around critical trends and actionable insights, this summary lays the groundwork for informed decision-making in a field defined by rapid innovation and interdisciplinary collaboration.

Pivotal Technological and Research Advances Reshaping microRNA Studies

The microRNA field is experiencing a technological renaissance driven by next-generation sequencing and single-cell profiling, which have vastly improved detection sensitivity and specificity. High-throughput platforms now enable the simultaneous quantification of hundreds of microRNAs, while improvements in library preparation and data-processing algorithms have accelerated discovery. Bioinformatics tools powered by machine learning are reshaping functional annotation, making it possible to predict microRNA-mRNA interactions with unprecedented accuracy.

Simultaneously, research paradigms have evolved from hypothesis-driven investigations to unbiased, omics-scale screens that uncover novel microRNA networks. This shift is fueling a wave of diagnostic innovation, with emerging assays for oncology, cardiovascular disease, and infectious agents receiving regulatory approvals in key markets. Collaborative consortia and public-private partnerships are further catalyzing the translation of microRNA biomarkers into clinical practice, creating a more integrated ecosystem that bridges academia, industry, and healthcare providers.

Assessing United States Tariffs Impact on microRNA Trade Dynamics

In 2025, the United States implemented tariffs affecting laboratory consumables and instrumentation imported from major global suppliers. The cumulative impact has been most pronounced in reagents and kits, where cost increases have filtered through to end-user budgets, prompting research institutions to reassess procurement strategies. Instruments such as sequencing systems and qPCR platforms have also seen price adjustments, leading some laboratories to delay capital investments or explore leasing models.

To mitigate these challenges, organizations have diversified their supply chains by engaging domestic manufacturers and regional distributors. Software and data analysis services have proved more resilient, as digital delivery models remain unaffected by import duties. Nonetheless, the tariff environment has underscored the importance of supply-chain agility and strategic sourcing, compelling microRNA market participants to reconfigure contractual frameworks and optimize inventory management to sustain research momentum.

Dissecting Market Segments Across Products Services and Applications

The market for microRNA tools and services can be segmented by product offerings, applications, and end-user categories to reveal nuanced growth drivers. Within product types, instrumentation comprises microarray, qPCR, and sequencing systems, with sequencing emerging as the primary workhorse for discovery applications. Kits and reagents span detection, extraction, library preparation, and profiling, where demand for streamlined workflows and high-sensitivity assays remains robust. Meanwhile, software and services encompass bioinformatics analytics, expert consultations, and data-visualization platforms, reflecting a broader trend toward outsourcing complex data interpretation.

When viewed through an application lens, basic research continues to anchor the market via functional genomics and gene expression profiling studies, yet diagnostics is gaining ground, particularly in oncology and infectious disease arenas. Drug discovery and development segments-focused on biomarker identification, target validation, and toxicology screening-are catalyzing partnerships between biotech firms and contract research organizations. End-user patterns reveal that academic and research institutes, from universities to specialized research centers, maintain the largest share of microRNA adoption, while contract research organizations operating in both preclinical and clinical domains are investing heavily in integrated platforms. Diagnostic laboratories, whether hospital-based or independent, are deploying assays for patient stratification, and pharmaceutical and biotechnology companies, including both established big-pharma players and agile biotech innovators, are building in-house capabilities to accelerate translational research.

Regional Dynamics Driving microRNA Research Adoption Worldwide

Regional dynamics play a pivotal role in shaping microRNA research and commercialization strategies. In the Americas, sustained research funding, robust regulatory support, and advanced healthcare systems have created a prolific environment for both academic exploration and diagnostic assay adoption. Collaborative networks between public institutions and private enterprises bolster a vibrant market ecosystem.

Europe, the Middle East & Africa exhibit a heterogeneous landscape where countries like Germany, the United Kingdom, and the Netherlands serve as hubs for translational research and clinical validation. Regulatory harmonization efforts and investment incentives are fostering innovation clusters, even as emerging markets in Eastern Europe and the Gulf region explore localized manufacturing of consumables.

Asia-Pacific stands out for rapid expansion fueled by national biotechnology initiatives in China, Japan, South Korea, and India. Rising public and private R&D expenditure, coupled with large patient populations and government-backed genomics programs, is accelerating the uptake of microRNA technologies. Regional players are increasingly collaborating with global vendors to tailor solutions for local research priorities and clinical needs.

Mapping the Competitive Terrain Among Leading microRNA Innovators

The competitive landscape is defined by a blend of established life-science giants and nimble specialized providers. Leading instrument manufacturers continue to refine platform capabilities, road-mapping enhancements in throughput, accuracy, and user experience. Concurrently, major reagent suppliers are focusing on expanding their portfolio of detection and extraction kits optimized for low-input RNA samples.

On the software and services front, bioinformatics firms are investing in artificial intelligence to automate annotation and predictive modeling, while consultancy groups with domain expertise in microRNA biology are capturing project-based engagements. Strategic collaborations, joint ventures, and targeted acquisitions remain prominent themes, allowing companies to augment their technological strengths and broaden their addressable markets. Emerging firms that deliver turnkey solutions-combining hardware, consumables, and analytics-are challenging traditional vendor silos and setting new benchmarks for integrated service delivery.

Strategic Actions to Navigate the Evolving microRNA Market Landscape

Industry leaders should prioritize the development of integrated platforms that seamlessly combine sequencing hardware with advanced bioinformatics pipelines to streamline workflows and reduce time-to-result. Given the volatility introduced by import tariffs, it is imperative to diversify supplier networks and explore local manufacturing partnerships to safeguard margins and ensure uninterrupted supply.

Expanding into diagnostics, particularly in oncology and infectious diseases, offers a pathway to higher-margin opportunities; companies can accelerate assay validation by leveraging real-world evidence from clinical collaborators. Strengthening ties with academic centers through co-development programs will facilitate early access to emerging biomarkers and foster brand recognition among thought leaders. Finally, a targeted expansion in high-growth Asia-Pacific markets-supported by tailored pricing strategies and regulatory navigation services-can unlock substantial upside in both research and clinical segments.

Robust Multi-Tiered Approach Ensuring Data Integrity and Insight

This analysis draws on a rigorous methodology combining primary and secondary research. In-depth interviews with key opinion leaders, laboratory directors, and industry executives provided firsthand perspectives on technology adoption and market evolution. Secondary sources included peer-reviewed publications, regulatory filings, patents, and corporate reports to validate technological trajectories and strategic initiatives.

Segmentation frameworks were constructed by mapping product categories, application domains, and end-user groups, ensuring a comprehensive view of market drivers. Qualitative insights were triangulated with company announcements and industry events to capture both historical context and emerging trends. Each data point underwent peer review to maintain analytical rigor and ensure the conclusions reflect the latest developments in microRNA research and commercialization.

Synthesizing Key Takeaways to Guide Future microRNA Endeavors

The microRNA market stands at a crossroads of technological ingenuity and translational promise. Advancements in high-throughput sequencing, enhanced assay sensitivity, and AI-driven analytics are converging to unlock new diagnostic and therapeutic frontiers. While external factors such as import tariffs introduce complexity, they also catalyze prudent supply-chain strategies and local innovation.

Stakeholders equipped with a clear understanding of product and application segmentation, regional nuances, and competitive positioning will be well-positioned to capitalize on the next wave of microRNA breakthroughs. By integrating the insights presented in this summary, decision-makers can chart a course that balances scientific ambition with operational resilience, ensuring sustainable growth in a dynamic market environment.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Product Type
    • Instruments
      • Microarray Systems
      • qPCR Systems
      • Sequencing Systems
    • Kits & Reagents
      • Detection Kits
      • Extraction Kits
      • Library Prep Kits
      • Profiling Kits
    • Software & Services
      • Bioinformatics Services
      • Consultation Services
      • Data Analysis Software
  • Application
    • Basic Research
      • Functional Genomics
      • Gene Expression Profiling
    • Diagnostics
      • Cancer Diagnostics
      • Cardiovascular Diagnostics
      • Infectious Disease Diagnostics
    • Drug Discovery & Development
      • Biomarker Discovery
      • Target Validation
      • Toxicology Studies
  • End User
    • Academic & Research Institutes
      • Research Institutes
      • Universities
    • Contract Research Organizations
      • Clinical
      • Preclinical
    • Diagnostic Laboratories
      • Hospital Labs
      • Independent Labs
    • Pharmaceutical & Biotechnology Companies
      • Big Pharma
      • Biotech Firms
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • Thermo Fisher Scientific Inc.
  • QIAGEN N.V.
  • Illumina, Inc.
  • Agilent Technologies, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Bio-Rad Laboratories, Inc.
  • Merck KGaA
  • Promega Corporation
  • NanoString Technologies, Inc.
  • Takara Bio Inc.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. microRNA Market, by Product Type
8.1. Introduction
8.2. Instruments
8.2.1. Microarray Systems
8.2.2. qPCR Systems
8.2.3. Sequencing Systems
8.3. Kits & Reagents
8.3.1. Detection Kits
8.3.2. Extraction Kits
8.3.3. Library Prep Kits
8.3.4. Profiling Kits
8.4. Software & Services
8.4.1. Bioinformatics Services
8.4.2. Consultation Services
8.4.3. Data Analysis Software
9. microRNA Market, by Application
9.1. Introduction
9.2. Basic Research
9.2.1. Functional Genomics
9.2.2. Gene Expression Profiling
9.3. Diagnostics
9.3.1. Cancer Diagnostics
9.3.2. Cardiovascular Diagnostics
9.3.3. Infectious Disease Diagnostics
9.4. Drug Discovery & Development
9.4.1. Biomarker Discovery
9.4.2. Target Validation
9.4.3. Toxicology Studies
10. microRNA Market, by End User
10.1. Introduction
10.2. Academic & Research Institutes
10.2.1. Research Institutes
10.2.2. Universities
10.3. Contract Research Organizations
10.3.1. Clinical
10.3.2. Preclinical
10.4. Diagnostic Laboratories
10.4.1. Hospital Labs
10.4.2. Independent Labs
10.5. Pharmaceutical & Biotechnology Companies
10.5.1. Big Pharma
10.5.2. Biotech Firms
11. Americas microRNA Market
11.1. Introduction
11.2. United States
11.3. Canada
11.4. Mexico
11.5. Brazil
11.6. Argentina
12. Europe, Middle East & Africa microRNA Market
12.1. Introduction
12.2. United Kingdom
12.3. Germany
12.4. France
12.5. Russia
12.6. Italy
12.7. Spain
12.8. United Arab Emirates
12.9. Saudi Arabia
12.10. South Africa
12.11. Denmark
12.12. Netherlands
12.13. Qatar
12.14. Finland
12.15. Sweden
12.16. Nigeria
12.17. Egypt
12.18. Turkey
12.19. Israel
12.20. Norway
12.21. Poland
12.22. Switzerland
13. Asia-Pacific microRNA Market
13.1. Introduction
13.2. China
13.3. India
13.4. Japan
13.5. Australia
13.6. South Korea
13.7. Indonesia
13.8. Thailand
13.9. Philippines
13.10. Malaysia
13.11. Singapore
13.12. Vietnam
13.13. Taiwan
14. Competitive Landscape
14.1. Market Share Analysis, 2024
14.2. FPNV Positioning Matrix, 2024
14.3. Competitive Analysis
14.3.1. Thermo Fisher Scientific Inc.
14.3.2. QIAGEN N.V.
14.3.3. Illumina, Inc.
14.3.4. Agilent Technologies, Inc.
14.3.5. F. Hoffmann-La Roche Ltd.
14.3.6. Bio-Rad Laboratories, Inc.
14.3.7. Merck KGaA
14.3.8. Promega Corporation
14.3.9. NanoString Technologies, Inc.
14.3.10. Takara Bio Inc.
15. ResearchAI
16. ResearchStatistics
17. ResearchContacts
18. ResearchArticles
19. Appendix
List of Figures
FIGURE 1. MICRORNA MARKET MULTI-CURRENCY
FIGURE 2. MICRORNA MARKET MULTI-LANGUAGE
FIGURE 3. MICRORNA MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL MICRORNA MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL MICRORNA MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL MICRORNA MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL MICRORNA MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL MICRORNA MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL MICRORNA MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL MICRORNA MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL MICRORNA MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL MICRORNA MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS MICRORNA MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS MICRORNA MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES MICRORNA MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES MICRORNA MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA MICRORNA MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA MICRORNA MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC MICRORNA MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC MICRORNA MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. MICRORNA MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. MICRORNA MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. MICRORNA MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL MICRORNA MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL MICRORNA MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL MICRORNA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL MICRORNA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL MICRORNA MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL MICRORNA MARKET SIZE, BY MICROARRAY SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL MICRORNA MARKET SIZE, BY QPCR SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL MICRORNA MARKET SIZE, BY SEQUENCING SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL MICRORNA MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL MICRORNA MARKET SIZE, BY KITS & REAGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL MICRORNA MARKET SIZE, BY DETECTION KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL MICRORNA MARKET SIZE, BY EXTRACTION KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL MICRORNA MARKET SIZE, BY LIBRARY PREP KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL MICRORNA MARKET SIZE, BY PROFILING KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL MICRORNA MARKET SIZE, BY KITS & REAGENTS, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL MICRORNA MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL MICRORNA MARKET SIZE, BY BIOINFORMATICS SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL MICRORNA MARKET SIZE, BY CONSULTATION SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL MICRORNA MARKET SIZE, BY DATA ANALYSIS SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL MICRORNA MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL MICRORNA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL MICRORNA MARKET SIZE, BY BASIC RESEARCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL MICRORNA MARKET SIZE, BY FUNCTIONAL GENOMICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL MICRORNA MARKET SIZE, BY GENE EXPRESSION PROFILING, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL MICRORNA MARKET SIZE, BY BASIC RESEARCH, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL MICRORNA MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL MICRORNA MARKET SIZE, BY CANCER DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL MICRORNA MARKET SIZE, BY CARDIOVASCULAR DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL MICRORNA MARKET SIZE, BY INFECTIOUS DISEASE DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL MICRORNA MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL MICRORNA MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL MICRORNA MARKET SIZE, BY BIOMARKER DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL MICRORNA MARKET SIZE, BY TARGET VALIDATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL MICRORNA MARKET SIZE, BY TOXICOLOGY STUDIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL MICRORNA MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL MICRORNA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL MICRORNA MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL MICRORNA MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL MICRORNA MARKET SIZE, BY UNIVERSITIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL MICRORNA MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL MICRORNA MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL MICRORNA MARKET SIZE, BY CLINICAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL MICRORNA MARKET SIZE, BY PRECLINICAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL MICRORNA MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL MICRORNA MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL MICRORNA MARKET SIZE, BY HOSPITAL LABS, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL MICRORNA MARKET SIZE, BY INDEPENDENT LABS, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL MICRORNA MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL MICRORNA MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL MICRORNA MARKET SIZE, BY BIG PHARMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL MICRORNA MARKET SIZE, BY BIOTECH FIRMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL MICRORNA MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 55. AMERICAS MICRORNA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 56. AMERICAS MICRORNA MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 57. AMERICAS MICRORNA MARKET SIZE, BY KITS & REAGENTS, 2018-2030 (USD MILLION)
TABLE 58. AMERICAS MICRORNA MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 59. AMERICAS MICRORNA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 60. AMERICAS MICRORNA MARKET SIZE, BY BASIC RESEARCH, 2018-2030 (USD MILLION)
TABLE 61. AMERICAS MICRORNA MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 62. AMERICAS MICRORNA MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 63. AMERICAS MICRORNA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 64. AMERICAS MICRORNA MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 65. AMERICAS MICRORNA MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 66. AMERICAS MICRORNA MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 67. AMERICAS MICRORNA MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 68. AMERICAS MICRORNA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 69. UNITED STATES MICRORNA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 70. UNITED STATES MICRORNA MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 71. UNITED STATES MICRORNA MARKET SIZE, BY KITS & REAGENTS, 2018-2030 (USD MILLION)
TABLE 72. UNITED STATES MICRORNA MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 73. UNITED STATES MICRORNA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 74. UNITED STATES MICRORNA MARKET SIZE, BY BASIC RESEARCH, 2018-2030 (USD MILLION)
TABLE 75. UNITED STATES MICRORNA MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 76. UNITED STATES MICRORNA MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 77. UNITED STATES MICRORNA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 78. UNITED STATES MICRORNA MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 79. UNITED STATES MICRORNA MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 80. UNITED STATES MICRORNA MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 81. UNITED STATES MICRORNA MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 82. UNITED STATES MICRORNA MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 83. CANADA MICRORNA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 84. CANADA MICRORNA MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 85. CANADA MICRORNA MARKET SIZE, BY KITS & REAGENTS, 2018-2030 (USD MILLION)
TABLE 86. CANADA MICRORNA MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 87. CANADA MICRORNA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 88. CANADA MICRORNA MARKET SIZE, BY BASIC RESEARCH, 2018-2030 (USD MILLION)
TABLE 89. CANADA MICRORNA MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 90. CANADA MICRORNA MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 91. CANADA MICRORNA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 92. CANADA MICRORNA MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 93. CANADA MICRORNA MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 94. CANADA MICRORNA MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 95. CANADA MICRORNA MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 96. MEXICO MICRORNA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 97. MEXICO MICRORNA MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 98. MEXICO MICRORNA MARKET SIZE, BY KITS & REAGENTS, 2018-2030 (USD MILLION)
TABLE 99. MEXICO MICRORNA MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 100. MEXICO MICRORNA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 101. MEXICO MICRORNA MARKET SIZE, BY BASIC RESEARCH, 2018-2030 (USD MILLION)
TABLE 102. MEXICO MICRORNA MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 103. MEXICO MICRORNA MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 104. MEXICO MICRORNA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 105. MEXICO MICRORNA MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 106. MEXICO MICRORNA MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 107. MEXICO MICRORNA MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 108. MEXICO MICRORNA MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 109. BRAZIL MICRORNA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 110. BRAZIL MICRORNA MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 111. BRAZIL MICRORNA MARKET SIZE, BY KITS & REAGENTS, 2018-2030 (USD MILLION)
TABLE 112. BRAZIL MICRORNA MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 113. BRAZIL MICRORNA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 114. BRAZIL MICRORNA MARKET SIZE, BY BASIC RESEARCH, 2018-2030 (USD MILLION)
TABLE 115. BRAZIL MICRORNA MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 116. BRAZIL MICRORNA MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 117. BRAZIL MICRORNA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 118. BRAZIL MICRORNA MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 119. BRAZIL MICRORNA MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 120. BRAZIL MICRORNA MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 121. BRAZIL MICRORNA MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 122. ARGENTINA MICRORNA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 123. ARGENTINA MICRORNA MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 124. ARGENTINA MICRORNA MARKET SIZE, BY KITS & REAGENTS, 2018-2030 (USD MILLION)
TABLE 125. ARGENTINA MICRORNA MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 126. ARGENTINA MICRORNA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 127. ARGENTINA MICRORNA MARKET SIZE, BY BASIC RESEARCH, 2018-2030 (USD MILLION)
TABLE 128. ARGENTINA MICRORNA MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 129. ARGENTINA MICRORNA MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 130. ARGENTINA MICRORNA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 131. ARGENTINA MICRORNA MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 132. ARGENTINA MICRORNA MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 133. ARGENTINA MICRORNA MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 134. ARGENTINA MICRORNA MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 135. EUROPE, MIDDLE EAST & AFRICA MICRORNA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 136. EUROPE, MIDDLE EAST & AFRICA MICRORNA MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 137. EUROPE, MIDDLE EAST & AFRICA MICRORNA MARKET SIZE, BY KITS & REAGENTS, 2018-2030 (USD MILLION)
TABLE 138. EUROPE, MIDDLE EAST & AFRICA MICRORNA MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 139. EUROPE, MIDDLE EAST & AFRICA MICRORNA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 140. EUROPE, MIDDLE EAST & AFRICA MICRORNA MARKET SIZE, BY BASIC RESEARCH, 2018-2030 (USD MILLION)
TABLE 141. EUROPE, MIDDLE EAST & AFRICA MICRORNA MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 142. EUROPE, MIDDLE EAST & AFRICA MICRORNA MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 143. EUROPE, MIDDLE EAST & AFRICA MICRORNA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 144. EUROPE, MIDDLE EAST & AFRICA MICRORNA MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 145. EUROPE, MIDDLE EAST & AFRICA MICRORNA MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 146. EUROPE, MIDDLE EAST & AFRICA MICRORNA MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 147. EUROPE, MIDDLE EAST & AFRICA MICRORNA MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 148. EUROPE, MIDDLE EAST & AFRICA MICRORNA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 149. UNITED KINGDOM MICRORNA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 150. UNITED KINGDOM MICRORNA MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 151. UNITED KINGDOM MICRORNA MARKET SIZE, BY KITS & REAGENTS, 2018-2030 (USD MILLION)
TABLE 152. UNITED KINGDOM MICRORNA MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 153. UNITED KINGDOM MICRORNA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 154. UNITED KINGDOM MICRORNA MARKET SIZE, BY BASIC RESEARCH, 2018-2030 (USD MILLION)
TABLE 155. UNITED KINGDOM MICRORNA MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 156. UNITED KINGDOM MICRORNA MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 157. UNITED KINGDOM MICRORNA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 158. UNITED KINGDOM MICRORNA MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 159. UNITED KINGDOM MICRORNA MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 160. UNITED KINGDOM MICRORNA MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 161. UNITED KINGDOM MICRORNA MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 162. GERMANY MICRORNA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 163. GERMANY MICRORNA MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 164. GERMANY MICRORNA MARKET SIZE, BY KITS & REAGENTS, 2018-2030 (USD MILLION)
TABLE 165. GERMANY MICRORNA MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 166. GERMANY MICRORNA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 167. GERMANY MICRORNA MARKET SIZE, BY BASIC RESEARCH, 2018-2030 (USD MILLION)
TABLE 168. GERMANY MICRORNA MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 169. GERMANY MICRORNA MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 170. GERMANY MICRORNA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 171. GERMANY MICRORNA MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 172. GERMANY MICRORNA MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 173. GERMANY MICRORNA MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 174. GERMANY MICRORNA MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 175. FRANCE MICRORNA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 176. FRANCE MICRORNA MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 177. FRANCE MICRORNA MARKET SIZE, BY KITS & REAGENTS, 2018-2030 (USD MILLION)
TABLE 178. FRANCE MICRORNA MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 179. FRANCE MICRORNA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 180. FRANCE MICRORNA MARKET SIZE, BY BASIC RESEARCH, 2018-2030 (USD MILLION)
TABLE 181. FRANCE MICRORNA MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 182. FRANCE MICRORNA MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 183. FRANCE MICRORNA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 184. FRANCE MICRORNA MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 185. FRANCE MICRORNA MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 186. FRANCE MICRORNA MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 187. FRANCE MICRORNA MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 188. RUSSIA MICRORNA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 189. RUSSIA MICRORNA MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 190. RUSSIA MICRORNA MARKET SIZE, BY KITS & REAGENTS, 2018-2030 (USD MILLION)
TABLE 191. RUSSIA MICRORNA MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 192. RUSSIA MICRORNA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 193. RUSSIA MICRORNA MARKET SIZE, BY BASIC RESEARCH, 2018-2030 (USD MILLION)
TABLE 194. RUSSIA MICRORNA MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 195. RUSSIA MICRORNA MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 196. RUSSIA MICRORNA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 197. RUSSIA MICRORNA MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 198. RUSSIA MICRORNA MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 199. RUSSIA MICRORNA MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 200. RUSSIA MICRORNA MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 201. ITALY MICRORNA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 202. ITALY MICRORNA MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 203. ITALY MICRORNA MARKET SIZE, BY KITS & REAGENTS, 2018-2030 (USD MILLION)
TABLE 204. ITALY MICRORNA MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 205. ITALY MICRORNA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 206. ITALY MICRORNA MARKET SIZE, BY BASIC RESEARCH, 2018-2030 (USD MILLION)
TABLE 207. ITALY MICRORNA MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 208. ITALY MICRORNA MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 209. ITALY MICRORNA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 210. ITALY MICRORNA MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 211. ITALY MICRORNA MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 212. ITALY MICRORNA MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 213. ITALY MICRORNA MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 214. SPAIN MICRORNA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 215. SPAIN MICRORNA MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 216. SPAIN MICRORNA MARKET SIZE, BY KITS & REAGENTS, 2018-2030 (USD MILLION)
TABLE 217. SPAIN MICRORNA MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 218. SPAIN MICRORNA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 219. SPAIN MICRORNA MARKET SIZE, BY BASIC RESEARCH, 2018-2030 (USD MILLION)
TABLE 220. SPAIN MICRORNA MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 221. SPAIN MICRORNA MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 222. SPAIN MICRORNA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 223. SPAIN MICRORNA MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 224. SPAIN MICRORNA MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 225. SPAIN MICRORNA MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 226. SPAIN MICRORNA MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 227. UNITED ARAB EMIRATES MICRORNA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 228. UNITED ARAB EMIRATES MICRORNA MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 229. UNITED ARAB EMIRATES MICRORNA MARKET SIZE, BY KITS & REAGENTS, 2018-2030 (USD MILLION)
TABLE 230. UNITED ARAB EMIRATES MICRORNA MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 231. UNITED ARAB EMIRATES MICRORNA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 232. UNITED ARAB EMIRATES MICRORNA MARKET SIZE, BY BASIC RESEARCH, 2018-2030 (USD MILLION)
TABLE 233. UNITED ARAB EMIRATES MICRORNA MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 234. UNITED ARAB EMIRATES MICRORNA MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 235. UNITED ARAB EMIRATES MICRORNA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 236. UNITED ARAB EMIRATES MICRORNA MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 237. UNITED ARAB EMIRATES MICRORNA MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 238. UNITED ARAB EMIRATES MICRORNA MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 239. UNITED ARAB EMIRATES MICRORNA MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 240. SAUDI ARABIA MICRORNA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 241. SAUDI ARABIA MICRORNA MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 242. SAUDI ARABIA MICRORNA MARKET SIZE, BY KITS & REAGENTS, 2018-2030 (USD MILLION)
TABLE 243. SAUDI ARABIA MICRORNA MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 244. SAUDI ARABIA MICRORNA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 245. SAUDI ARABIA MICRORNA MARKET SIZE, BY BASIC RESEARCH, 2018-2030 (USD MILLION)
TABLE 246. SAUDI ARABIA MICRORNA MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 247. SAUDI ARABIA MICRORNA MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 248. SAUDI ARABIA MICRORNA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 249. SAUDI ARABIA MICRORNA MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 250. SAUDI ARABIA MICRORNA MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 251. SAUDI ARABIA MICRORNA MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 252. SAUDI ARABIA MICRORNA MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 253. SOUTH AFRICA MICRORNA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 254. SOUTH AFRICA MICRORNA MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 255. SOUTH AFRICA MICRORNA MARKET SIZE, BY KITS & REAGENTS, 2018-2030 (USD MILLION)
TABLE 256. SOUTH AFRICA MICRORNA MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 257. SOUTH AFRICA MICRORNA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 258. SOUTH AFRICA MICRORNA MARKET SIZE, BY BASIC RESEARCH, 2018-2030 (USD MILLION)
TABLE 259. SOUTH AFRICA MICRORNA MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 260. SOUTH AFRICA MICRORNA MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 261. SOUTH AFRICA MICRORNA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 262. SOUTH AFRICA MICRORNA MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 263. SOUTH AFRICA MICRORNA MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 264. SOUTH AFRICA MICRORNA MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 265. SOUTH AFRICA MICRORNA MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 266. DENMARK MICRORNA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 267. DENMARK MICRORNA MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 268. DENMARK MICRORNA MARKET SIZE, BY KITS & REAGENTS, 2018-2030 (USD MILLION)
TABLE 269. DENMARK MICRORNA MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 270. DENMARK MICRORNA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 271. DENMARK MICRORNA MARKET SIZE, BY BASIC RESEARCH, 2018-2030 (USD MILLION)
TABLE 272. DENMARK MICRORNA MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 273. DENMARK MICRORNA MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 274. DENMARK MICRORNA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 275. DENMARK MICRORNA MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 276. DENMARK MICRORNA MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 277. DENMARK MICRORNA MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 278. DENMARK MICRORNA MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 279. NETHERLANDS MICRORNA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 280. NETHERLANDS MICRORNA MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 281. NETHERLANDS MICRORNA MARKET SIZE, BY KITS & REAGENTS, 2018-2030 (USD MILLION)
TABLE 282. NETHERLANDS MICRORNA MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 283. NETHERLANDS MICRORNA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 284. NETHERLANDS MICRORNA MARKET SIZE, BY BASIC RESEARCH, 2018-2030 (USD MILLION)
TABLE 285. NETHERLANDS MICRORNA MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 286. NETHERLANDS MICRORNA MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 287. NETHERLANDS MICRORNA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 288. NETHERLANDS MICRORNA MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 289. NETHERLANDS MICRORNA MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 290. NETHERLANDS MICRORNA MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 291. NETHERLANDS MICRORNA MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 292. QATAR MICRORNA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 293. QATAR MICRORNA MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 294. QATAR MICRORNA MARKET SIZE, BY KITS & REAGENTS, 2018-2030 (USD MILLION)
TABLE 295. QATAR MICRORNA MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 296. QATAR MICRORNA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 297. QATAR MICRORNA MARKET SIZE, BY BASIC RESEARCH, 2018-2030 (USD MILLION)
TABLE 298. QATAR MICRORNA MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 299. QATAR MICRORNA MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 300. QATAR MICRORNA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 301. QATAR MICRORNA MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 302. QATAR MICRORNA MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 303. QATAR MICRORNA MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 304. QATAR MICRORNA MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 305. FINLAND MICRORNA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 306. FINLAND MICRORNA MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 307. FINLAND MICRORNA MARKET SIZE, BY KITS & REAGENTS, 2018-2030 (USD MILLION)
TABLE 308. FINLAND MICRORNA MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 309. FINLAND MICRORNA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 310. FINLAND MICRORNA MARKET SIZE, BY BASIC RESEARCH, 2018-2030 (USD MILLION)
TABLE 311. FINLAND MICRORNA MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 312. FINLAND MICRORNA MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 313. FINLAND MICRORNA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 314. FINLAND MICRORNA MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 315. FINLAND MICRORNA MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 316. FINLAND MICRORNA MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 317. FINLAND MICRORNA MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 318. SWEDEN MICRORNA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 319. SWEDEN MICRORNA MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 320. SWEDEN MICRORNA MARKET SIZE, BY KITS & REAGENTS, 2018-2030 (USD MILLION)
TABLE 321. SWEDEN MICRORNA MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 322. SWEDEN MICRORNA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 323. SWEDEN MICRORNA MARKET SIZE, BY BASIC RESEARCH, 2018-2030 (USD MILLION)
TABLE 324. SWEDEN MICRORNA MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 325. SWEDEN MICRORNA MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 326. SWEDEN MICRORNA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 327. SWEDEN MICRORNA MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 328. SWEDEN MICRORNA MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 329. SWEDEN MICRORNA MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 330. SWEDEN MICRORNA MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 331. NIGERIA MICRORNA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 332. NIGERIA MICRORNA MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 333. NIGERIA MICRORNA MARKET SIZE, BY KITS & REAGENTS, 2018-2030 (USD MILLION)
TABLE 334. NIGERIA MICRORNA MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 335. NIGERIA MICRORNA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 336. NIGERIA MICRORNA MARKET SIZE, BY BASIC RESEARCH, 2018-2030 (USD MILLION)
TABLE 337. NIGERIA MICRORNA MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 338. NIGERIA MICRORNA MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 339. NIGERIA MICRORNA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 340. NIGERIA MICRORNA MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 341. NIGERIA MICRORNA MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 342. NIGERIA MICRORNA MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 343. NIGERIA MICRORNA MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 344. EGYPT MICRORNA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 345. EGYPT MICRORNA MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 346. EGYPT MICRORNA MARKET SIZE, BY KITS & REAGENTS, 2018-2030 (USD MILLION)
TABLE 347. EGYPT MICRORNA MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 348. EGYPT MICRORNA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 349. EGYPT MICRORNA MARKET SIZE, BY BASIC RESEARCH, 2018-2030 (USD MILLION)
TABLE 350. EGYPT MICRORNA MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 351. EGYPT MICRORNA MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 352. EGYPT MICRORNA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 353. EGYPT MICRORNA MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 354. EGYPT MICRORNA MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 355. EGYPT MICRORNA MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 356. EGYPT MICRORNA MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 357. TURKEY MICRORNA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 358. TURKEY MICRORNA MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 359. TURKEY MICRORNA MARKET

Companies Mentioned

The companies profiled in this microRNA market report include:
  • Thermo Fisher Scientific Inc.
  • QIAGEN N.V.
  • Illumina, Inc.
  • Agilent Technologies, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Bio-Rad Laboratories, Inc.
  • Merck KGaA
  • Promega Corporation
  • NanoString Technologies, Inc.
  • Takara Bio Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages181
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 3.54 Billion
Forecasted Market Value ( USD ) by 2030 $ 12.55 Billion
Compound Annual Growth Rate28.9%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

MicroRNA Market Report 2025 - Product Image

MicroRNA Market Report 2025

  • Report
  • 200 Pages
  • Global
From
MicroRNA Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

MicroRNA Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 185 Pages
  • Global
From
microRNA (miRNA) - Global Strategic Business Report - Product Image

microRNA (miRNA) - Global Strategic Business Report

  • Report
  • 379 Pages
  • Global
From
Microrna (mirna) Market 2024-2028 - Product Image

Microrna (mirna) Market 2024-2028

  • Report
  • 166 Pages
  • Global
From
RNA Targeting Small Molecule Drug Discovery Market Report 2025 - Product Image

RNA Targeting Small Molecule Drug Discovery Market Report 2025

  • Report
  • 200 Pages
  • Global
From

About the MicroRNA Market

The MicroRNA market is a subset of the genomics industry that focuses on the study of small, non-coding RNA molecules. MicroRNAs are involved in a variety of biological processes, including gene expression, development, and disease. They are increasingly being studied as potential therapeutic targets for a variety of diseases, including cancer, cardiovascular disease, and neurological disorders. The market for microRNA-based therapeutics is growing rapidly, driven by advances in sequencing technology and the development of new delivery systems. Companies are developing a variety of products, including diagnostics, therapeutics, and research tools. Some of the major players in the microRNA market include Thermo Fisher Scientific, Illumina, Qiagen, Merck, and Novartis. Other companies, such as Exiqon, Bio-Rad, and Bio-Techne, are also active in the market. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.